BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Catalyst Biosciences, Inc. 

260 Littlefield Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-871-0761 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






 Company News
Catalyst Biosciences, Inc. and ISU ABXIS CO., LTD Announce Collaboration to Develop Next-Generation Best-In-Class Factor IX Therapeutics 10/9/2013 9:50:09 AM    More...
Pfizer Inc. (PFE) Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences, Inc. 1/5/2012 10:56:23 AM    More...
Catalyst Biosciences, Inc. Receives $4 Million Milestone Payment from Pfizer Inc. (PFE) for Progress in Lead Hemostasis Program 12/16/2010 6:42:47 AM    More...
Catalyst Biosciences, Inc. Appoints William J. Dawson Chief Financial Officer 3/2/2010 11:42:17 AM    More...
Catalyst Biosciences, Inc. Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics; Catalyst Will Receive Milestone up to $195 Million 7/7/2009 7:20:08 AM    More...
Wyeth (WYE), Catalyst Biosciences, Inc. Sign Deal Worth Potentially $500 Million 6/30/2009 7:03:35 AM    More...
Catalyst Biosciences, Inc. Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development 3/24/2009 12:12:44 PM    More...
Catalyst Biosciences, Inc. Raises $40 Million in Series C Financing 12/3/2008 6:42:53 AM    More...
Catalyst Biosciences, Inc. Appoints Dr. Todd Lorenz Chief Medical Officer 10/28/2008 8:14:08 AM    More...
Catalyst Biosciences, Inc. Selects Drug Development Candidate in Factor VIIa Program for Hemophilia 5/7/2008 7:24:59 AM    More...
123

//-->